Cargando…
Genomic and Immunogenic Protein Diversity of Erysipelothrix rhusiopathiae Isolated From Pigs in Great Britain: Implications for Vaccine Protection
Erysipelas, caused by the bacterium Erysipelothrix rhusiopathiae, is re-emerging in swine and poultry production systems worldwide. While the global genomic diversity of this species has been characterized, how much of this genomic and functional diversity is maintained at smaller scales is unclear....
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7083082/ https://www.ncbi.nlm.nih.gov/pubmed/32231655 http://dx.doi.org/10.3389/fmicb.2020.00418 |
_version_ | 1783508471466950656 |
---|---|
author | Forde, Taya L. Kollanandi Ratheesh, Nichith Harvey, William T. Thomson, Jill R. Williamson, Susanna Biek, Roman Opriessnig, Tanja |
author_facet | Forde, Taya L. Kollanandi Ratheesh, Nichith Harvey, William T. Thomson, Jill R. Williamson, Susanna Biek, Roman Opriessnig, Tanja |
author_sort | Forde, Taya L. |
collection | PubMed |
description | Erysipelas, caused by the bacterium Erysipelothrix rhusiopathiae, is re-emerging in swine and poultry production systems worldwide. While the global genomic diversity of this species has been characterized, how much of this genomic and functional diversity is maintained at smaller scales is unclear. Specifically, while several key immunogenic surface proteins have been identified for E. rhusiopathiae, little is known about their presence among field strains and their divergence from vaccines, which could result in vaccine failure. Here, a comparative genomics approach was taken to determine the diversity of E. rhusiopathiae strains in pigs in Great Britain over nearly three decades, as well as to assess the field strains’ divergence from the vaccine strain most commonly used in British pigs. In addition, the presence/absence and variability of 13 previously described immunogenic surface proteins was determined, including SpaA which is considered a key immunogen. We found a high diversity of E. rhusiopathiae strains in British pigs, similar to the situation described in European poultry but in contrast to swine production systems in Asia. Of the four clades of E. rhusiopathiae found globally, three were represented among British pig isolates, with Clade 2 being the most common. All British pig isolates had one amino acid difference in the immunoprotective domain of the SpaA protein compared to the vaccine strain. However, we were able to confirm using in silico structural protein analyses that this difference is unlikely to compromise vaccine protection. Of 12 other known immunogenic surface proteins of E. rhusiopathiae examined, 11 were found to be present in all British pig isolates and the vaccine strain, but with highly variable degrees of conservation at the amino acid sequence level, ranging from 0.3 to 27% variant positions. Moreover, the phylogenetic incongruence of these proteins suggests that horizontal transfer of genes encoding for antigens is commonplace for this bacterium. We hypothesize that the sequence variants in these proteins could be responsible for differences in the efficacy of the immune response. Our results provide the necessary basis for testing this hypothesis through in vitro and in vivo studies. |
format | Online Article Text |
id | pubmed-7083082 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-70830822020-03-30 Genomic and Immunogenic Protein Diversity of Erysipelothrix rhusiopathiae Isolated From Pigs in Great Britain: Implications for Vaccine Protection Forde, Taya L. Kollanandi Ratheesh, Nichith Harvey, William T. Thomson, Jill R. Williamson, Susanna Biek, Roman Opriessnig, Tanja Front Microbiol Microbiology Erysipelas, caused by the bacterium Erysipelothrix rhusiopathiae, is re-emerging in swine and poultry production systems worldwide. While the global genomic diversity of this species has been characterized, how much of this genomic and functional diversity is maintained at smaller scales is unclear. Specifically, while several key immunogenic surface proteins have been identified for E. rhusiopathiae, little is known about their presence among field strains and their divergence from vaccines, which could result in vaccine failure. Here, a comparative genomics approach was taken to determine the diversity of E. rhusiopathiae strains in pigs in Great Britain over nearly three decades, as well as to assess the field strains’ divergence from the vaccine strain most commonly used in British pigs. In addition, the presence/absence and variability of 13 previously described immunogenic surface proteins was determined, including SpaA which is considered a key immunogen. We found a high diversity of E. rhusiopathiae strains in British pigs, similar to the situation described in European poultry but in contrast to swine production systems in Asia. Of the four clades of E. rhusiopathiae found globally, three were represented among British pig isolates, with Clade 2 being the most common. All British pig isolates had one amino acid difference in the immunoprotective domain of the SpaA protein compared to the vaccine strain. However, we were able to confirm using in silico structural protein analyses that this difference is unlikely to compromise vaccine protection. Of 12 other known immunogenic surface proteins of E. rhusiopathiae examined, 11 were found to be present in all British pig isolates and the vaccine strain, but with highly variable degrees of conservation at the amino acid sequence level, ranging from 0.3 to 27% variant positions. Moreover, the phylogenetic incongruence of these proteins suggests that horizontal transfer of genes encoding for antigens is commonplace for this bacterium. We hypothesize that the sequence variants in these proteins could be responsible for differences in the efficacy of the immune response. Our results provide the necessary basis for testing this hypothesis through in vitro and in vivo studies. Frontiers Media S.A. 2020-03-13 /pmc/articles/PMC7083082/ /pubmed/32231655 http://dx.doi.org/10.3389/fmicb.2020.00418 Text en Copyright © 2020 Forde, Kollanandi Ratheesh, Harvey, Thomson, Williamson, Biek and Opriessnig. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Microbiology Forde, Taya L. Kollanandi Ratheesh, Nichith Harvey, William T. Thomson, Jill R. Williamson, Susanna Biek, Roman Opriessnig, Tanja Genomic and Immunogenic Protein Diversity of Erysipelothrix rhusiopathiae Isolated From Pigs in Great Britain: Implications for Vaccine Protection |
title | Genomic and Immunogenic Protein Diversity of Erysipelothrix rhusiopathiae Isolated From Pigs in Great Britain: Implications for Vaccine Protection |
title_full | Genomic and Immunogenic Protein Diversity of Erysipelothrix rhusiopathiae Isolated From Pigs in Great Britain: Implications for Vaccine Protection |
title_fullStr | Genomic and Immunogenic Protein Diversity of Erysipelothrix rhusiopathiae Isolated From Pigs in Great Britain: Implications for Vaccine Protection |
title_full_unstemmed | Genomic and Immunogenic Protein Diversity of Erysipelothrix rhusiopathiae Isolated From Pigs in Great Britain: Implications for Vaccine Protection |
title_short | Genomic and Immunogenic Protein Diversity of Erysipelothrix rhusiopathiae Isolated From Pigs in Great Britain: Implications for Vaccine Protection |
title_sort | genomic and immunogenic protein diversity of erysipelothrix rhusiopathiae isolated from pigs in great britain: implications for vaccine protection |
topic | Microbiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7083082/ https://www.ncbi.nlm.nih.gov/pubmed/32231655 http://dx.doi.org/10.3389/fmicb.2020.00418 |
work_keys_str_mv | AT fordetayal genomicandimmunogenicproteindiversityoferysipelothrixrhusiopathiaeisolatedfrompigsingreatbritainimplicationsforvaccineprotection AT kollanandiratheeshnichith genomicandimmunogenicproteindiversityoferysipelothrixrhusiopathiaeisolatedfrompigsingreatbritainimplicationsforvaccineprotection AT harveywilliamt genomicandimmunogenicproteindiversityoferysipelothrixrhusiopathiaeisolatedfrompigsingreatbritainimplicationsforvaccineprotection AT thomsonjillr genomicandimmunogenicproteindiversityoferysipelothrixrhusiopathiaeisolatedfrompigsingreatbritainimplicationsforvaccineprotection AT williamsonsusanna genomicandimmunogenicproteindiversityoferysipelothrixrhusiopathiaeisolatedfrompigsingreatbritainimplicationsforvaccineprotection AT biekroman genomicandimmunogenicproteindiversityoferysipelothrixrhusiopathiaeisolatedfrompigsingreatbritainimplicationsforvaccineprotection AT opriessnigtanja genomicandimmunogenicproteindiversityoferysipelothrixrhusiopathiaeisolatedfrompigsingreatbritainimplicationsforvaccineprotection |